Location: Ny
CIK: 0002003147 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 14, 2026
Total Value: $365M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | 1,593,942 | $44.76M | 12.3% | $25.03 | +4.6% | COM | 717081103 |
| REGN | REGENERON PHARMACEUTICALS | 44,800 | $34.61M | 9.5% | $678.68 | +13.3% | COM | 75886F107 |
| INSM | INSMED INC | 182,562 | $29.85M | 8.2% | $159.03 | 0.0% | COM PAR $.01 | 457669307 |
| IONS | IONIS PHARMACEUTICALS INC | 386,903 | $29.05M | 8.0% | $77.79 | +5.2% | COM | 462222100 |
| NTRA | NATERA INC | 143,966 | $28.79M | 7.9% | $216.43 | +4.4% | COM | 632307104 |
| BNTX | BIONTECH SE | 305,055 | $27.11M | 7.4% | $95.20 | — | SPONSORED ADS | 09075V102 |
| ARGX | ARGENX SE | 35,045 | $25.59M | 7.0% | $840.95 | — | SPONSORED ADR | 04016X101 |
| LLY | ELI LILLY & CO | 27,279 | $25.09M | 6.9% | $1019.21 | +2.7% | COM | 532457108 |
| RPRX | ROYALTY PHARMA PLC | 520,009 | $24.94M | 6.8% | $38.13 | +10.9% | SHS CLASS A | G7709Q104 |
| ROIV | ROIVANT SCIENCES LTD | 873,398 | $24.19M | 6.6% | $19.73 | +22.5% | SHS | G76279101 |
| LEGN | LEGEND BIOTECH CORP | 1,314,748 | $23.78M | 6.5% | $21.02 | — | SPONSORED ADS | 52490G102 |
| MLYS | MINERALYS THERAPEUTICS INC | 447,153 | $12.11M | 3.3% | $35.48 | -11.6% | COM | 603170101 |
| ABVX | ABIVAX SA | 78,125 | $8.699M | 2.4% | $125.94 | — | SPONSORED ADS | 00370M103 |
| GENB | GENERATE BIOMEDICINES INC | 591,800 | $7.397M | 2.0% | $12.50 | — | COM SHS | 370920100 |
| PRCT | PROCEPT BIOROBOTICS CORP | 261,200 | $6.533M | 1.8% | $29.57 | 0.0% | COM | 74276L105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 126,461 | $6.095M | 1.7% | $48.20 | — | SPONSORED ADS | 86366E106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 302,457 | $5.916M | 1.6% | $27.89 | +10.6% | COM | 92790C104 |